Invictus Private Wealth, LLC Harrow Health, Inc. Transaction History

Invictus Private Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$8.1 - $16.36 $3.07 Million - $6.2 Million	-379,066 Reduced 94.75%	21,000 $235 Million
Q3 2023 Oct 04, 2023	SELL	$14.03 - $22.08 $1.52 Million - $2.39 Million	-108,250 Reduced 21.3%	400,066 $5.75 Billion
Q2 2023 Aug 24, 2023	SELL	$17.37 - $28.08 $2.28 Million - $3.68 Million	-131,000 Reduced 20.49%	508,316 $9.68 Billion
Q1 2023 Jun 05, 2023	SELL	$13.84 - $21.46 $1.87 Million - $2.89 Million	-134,806 Reduced 17.41%	639,316 $13.5 Billion
Q4 2022 Jun 05, 2023	BUY	$10.28 - $14.78 $7.96 Million - $11.4 Million	774,122 New	774,122 $11.4 Billion

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $950M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Invictus Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Invictus Private Wealth, LLC with notifications on news.